Literature DB >> 27956702

Snail-Modulated MicroRNA 493 Forms a Negative Feedback Loop with the Insulin-Like Growth Factor 1 Receptor Pathway and Blocks Tumorigenesis.

Arathy S Kumar1, Sankar Jagadeeshan1, Ravi Shankar Pitani2, Vijayalakshmi Ramshankar3, Kesavan Venkitasamy1, Ganesh Venkatraman4, Suresh K Rayala5.   

Abstract

In this study, we have identified one microRNA, microRNA 493 (miR-493), which could simultaneously and directly regulate multiple genes downstream of the insulin-like growth factor 1 receptor (IGF1R) pathway, including IGF1R, by binding with complementary sequences in the 3' untranslated region (UTR) of mRNAs of IGF1R, insulin receptor substrate 1 (IRS1), and mitogen-activated protein kinase 1 (MAPK1), thereby potentiating their inhibitory function at multiple levels in development and progression of cancers. This binding was further confirmed by pulldown of miR with AGO-2 antibody. Further, results from head and neck samples showed that miR-493 levels were significantly downregulated in tumors, with a concomitant increase in the expression of IGF1R and key downstream effectors. Functional studies from miR-493 overexpression cells and nude-mouse models revealed the tumor suppressor functions of miR-493. Regulation studies revealed that Snail binds to the miR-493 promoter and represses it. We found the existence of a dynamic negative feedback loop in the regulation of IGF1R and miR-493 mediated via Snail. Our study showed that nicotine treatment significantly decreases the levels of miR-493-with a concomitant increase in the levels of Snail-an indication of progression of cells toward tumorigenesis, reestablishing the role of tobacco as a major risk factor for head and neck cancers and elucidating the mechanism behind nicotine-mediated tumorigenesis.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  IGF1R; Snail; feedback loop; miR-493; nicotine

Mesh:

Substances:

Year:  2017        PMID: 27956702      PMCID: PMC5335515          DOI: 10.1128/MCB.00510-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  84 in total

1.  Insulin-like Growth Factor-I signaling mechanisms, type I collagen and alpha smooth muscle actin in human fetal lung fibroblasts.

Authors:  Anne Chetty; Gong-Jee Cao; Heber C Nielsen
Journal:  Pediatr Res       Date:  2006-08-28       Impact factor: 3.756

2.  Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.

Authors:  Hua Zhang; Alissa M Pelzer; David T Kiang; Douglas Yee
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 3.  Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers.

Authors:  Courtney Schaal; Srikumar P Chellappan
Journal:  Mol Cancer Res       Date:  2014-01-07       Impact factor: 5.852

Review 4.  Insulin-like growth factor: current concepts and new developments in cancer therapy.

Authors:  Erin R King; Kwong-Kwok Wong
Journal:  Recent Pat Anticancer Drug Discov       Date:  2012-01       Impact factor: 4.169

5.  NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors.

Authors:  Vivian Y Shin; Hongchuan Jin; Enders K O Ng; Alfred S L Cheng; Wilson W S Chong; Christine Y P Wong; Wai K Leung; Joseph J Y Sung; Kent-Man Chu
Journal:  Carcinogenesis       Date:  2010-11-15       Impact factor: 4.944

6.  Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.

Authors:  Marianna Sadagurski; Shoshana Yakar; Galina Weingarten; Martin Holzenberger; Christopher J Rhodes; Dirk Breitkreutz; Derek Leroith; Efrat Wertheimer
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 7.  Regulation of IGF -1 signaling by microRNAs.

Authors:  Hwa Jin Jung; Yousin Suh
Journal:  Front Genet       Date:  2015-01-13       Impact factor: 4.599

8.  Accurate microRNA target prediction correlates with protein repression levels.

Authors:  Manolis Maragkakis; Panagiotis Alexiou; Giorgio L Papadopoulos; Martin Reczko; Theodore Dalamagas; George Giannopoulos; George Goumas; Evangelos Koukis; Kornilios Kourtis; Victor A Simossis; Praveen Sethupathy; Thanasis Vergoulis; Nectarios Koziris; Timos Sellis; Panagiotis Tsanakas; Artemis G Hatzigeorgiou
Journal:  BMC Bioinformatics       Date:  2009-09-18       Impact factor: 3.169

Review 9.  MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas.

Authors:  Dan Chen; Robert J Cabay; Yi Jin; Anxun Wang; Yang Lu; Muzaffar Shah-Khan; Xiaofeng Zhou
Journal:  J Oral Maxillofac Res       Date:  2013-04-01

10.  MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1.

Authors:  Yixue Gu; Ye Cheng; Ying Song; Zhijie Zhang; Min Deng; Chengkun Wang; Guopei Zheng; Zhimin He
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

View more
  6 in total

Review 1.  Targeting IGF1R pathway in cancer with microRNAs: How close are we?

Authors:  Arathy S Kumar; Suresh K Rayala; Ganesh Venkatraman
Journal:  RNA Biol       Date:  2018-02-01       Impact factor: 4.652

2.  Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.

Authors:  Jiangfeng Li; Shuai Meng; Mingjie Xu; Song Wang; Liujia He; Xin Xu; Xiao Wang; Liping Xie
Journal:  Oncotarget       Date:  2017-12-18

3.  c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer.

Authors:  Song Wang; Xiao Wang; Jiangfeng Li; Shuai Meng; Zhen Liang; Xin Xu; Yi Zhu; Shiqi Li; Jian Wu; Mingjie Xu; Alin Ji; Yiwei Lin; Ben Liu; Xiangyi Zheng; Bo Xie; Liping Xie
Journal:  Oncotarget       Date:  2017-07-19

Review 4.  Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers.

Authors:  Jiangfeng Li; Haixiang Shen; Haiyun Xie; Yufan Ying; Ke Jin; Huaqing Yan; Song Wang; Mingjie Xu; Xiao Wang; Xin Xu; Liping Xie
Journal:  Cancer Manag Res       Date:  2019-01-15       Impact factor: 3.989

5.  The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1.

Authors:  Xiao Zhang; Peng Li; Zhen Ding; Huili Wang; Junye Wang; Lei Han; Shangwei Ding
Journal:  Onco Targets Ther       Date:  2017-12-27       Impact factor: 4.147

6.  miR-491-3p is Downregulated in Retinoblastoma and Inhibit Tumor Cells Growth and Metastasis by Targeting SNN.

Authors:  Yang Hu; Ming Zhao; Li Li; Jie Ding; Yu-Min Gui; Tan-Wei Wei
Journal:  Biochem Genet       Date:  2020-10-23       Impact factor: 1.890

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.